Skip to main content

1 Result(s)

within Saori Fukui Remove this filter

and

  1. Article

    Open Access

    Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial

    High-dose intravenous immunoglobulin (IVIG) is the mainstay of treatment for Kawasaki disease (KD). Usually, 2 g/kg of IVIG is administered over 10–24 h, depending on the institution or physician, but the asso...

    Saori Fukui, Mitsuru Seki, Takaomi Minami, Kazuhiko Kotani… in Pediatric Rheumatology (2021)

    Download PDF (518 KB) View Article